Last A$1.50 AUD
Change Today 0.00 / 0.00%
Volume 0.0
VSC On Other Exchanges
Symbol
Exchange
Frankfurt
As of 12:53 AM 10/22/14 All times are local (Market data is delayed by at least 15 minutes).

vita life sciences ltd (VSC) Snapshot

Open
A$1.51
Previous Close
A$1.50
Day High
A$1.51
Day Low
A$1.50
52 Week High
02/19/14 - A$1.85
52 Week Low
12/11/13 - A$1.25
Market Cap
85.3M
Average Volume 10 Days
12.6K
EPS TTM
A$0.13
Shares Outstanding
56.9M
EX-Date
09/16/14
P/E TM
11.5x
Dividend
A$0.04
Dividend Yield
2.33%
Current Stock Chart for VITA LIFE SCIENCES LTD (VSC)

Related News

No related news articles were found.

vita life sciences ltd (VSC) Related Businessweek News

No Related Businessweek News Found

vita life sciences ltd (VSC) Details

Vita Life Sciences Limited is engaged in formulating, packaging, selling, and distributing vitamins and supplements. The company operates in two segments, Health and Investment. It offers a range of supplements, vitamins, minerals, meal replacement, sports nutrition, and herbals for men, women, and children; and over the counter products. The company markets its products through pharmacies and health food stores primarily under the VitaHealth and Herbs of Gold brand names. It operates in Australia, Malaysia, Singapore, and internationally. Vita Life Sciences Limited was founded in 1947 and is headquartered in Melbourne, Australia.

Founded in 1947

vita life sciences ltd (VSC) Top Compensated Officers

Managing Director and Executive Director
Total Annual Compensation: A$130.6K
Senior General Manager of Asian Business and ...
Total Annual Compensation: A$243.3K
General Manager of Thailand
Total Annual Compensation: A$85.8K
Compensation as of Fiscal Year 2013.

vita life sciences ltd (VSC) Key Developments

Vita Life Sciences Limited Declares Unfranked Interim Dividend for the Half Year Ended June 30, 2014, Payable on September 25, 2014; Reports Unaudited Consolidated Earnings Results for the Half Year Ended June 30, 2014; Provides Earnings Guidance for the Full Year 2014

Vita Life Sciences Limited declared unfranked interim dividend for the half year ended June 30, 2014, of 1.5 cents per share compared to 1.0 cent per share for the same period last year. The dividend will be paid on September 25, 2014. The record date for the interim dividend is September 18, 2014 and ex-dividend of September 16, 2014. The company reported unaudited consolidated earnings results for the half year ended June 30, 2014. For the half year, the company reported sale of goods of AUD 17,739,000 compared to AUD 17,083,000 for the same period a year ago. Profit from continuing operations before interest and taxes was AUD 3,315,000 compared to AUD 2,542,000 a year ago. Profit before income tax was AUD 3,337,000 compared to AUD 2,538,000 a year ago. Profit attributable to members of the parent was AUD 4,661,000 or 8.20 cents per diluted share compared to AUD 2,136,000 or 3.79 cents per diluted share a year ago. Net cash flows provided by operating activities was AUD 2,978,000 compared to AUD 2,538,000 a year ago. Purchase of property, plant and equipment was AUD 617,000 compared to AUD 183,000 a year ago. EBITDA was AUD 3.36 million compared to AUD 2.63 million a year ago. EBIT was AUD 3.31 million compared to AUD 2.54 million a year ago. For the full year 2014, the company’s revenue guidance is AUD 37 million to AUD 38 million and EBIT guidance is AUD 6.5 million to AUD 7.0 million.

Vita Life Sciences Limited Announces Executive Changes

Vita Life Sciences Limited announced that at a meeting of Directors on May 21, 2014, Mr. Vanda Gould, a Non-Executive Director of the company, was appointed Chairman. Mr. Eddie Tie stepped down from the position of acting Chairman. Mr. Tie remains the Company's Managing Director.

Vita Life Sciences Limited, Annual General Meeting, May 22, 2014

Vita Life Sciences Limited, Annual General Meeting, May 22, 2014., at 14:30 AUS Eastern Standard Time. Location: Institute of Chartered Accountants Function Centre. Agenda: To receive and consider the financial statements and the reports of the directors and the auditors of the company for the year ended December 31, 2013; to consider the remuneration report for the year ended December 31, 2013; to consider re-election of Director; to consider long term incentive plan; to consider share buy-back; and to consider any other business that may be properly brought forward at the meeting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSC:AU A$1.50 AUD 0.00

VSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VSC.
View Industry Companies
 

Industry Analysis

VSC

Industry Average

Valuation VSC Industry Range
Price/Earnings 10.9x
Price/Sales 2.2x
Price/Book 4.2x
Price/Cash Flow 10.9x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VITA LIFE SCIENCES LTD, please visit www.vitalifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.